The report offers detailed coverage of Anti-Obesity Prescription Drugs industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Anti-Obesity Prescription Drugs by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Growing demand for obesity is one of the recent trends in the global Anti-Obesity Prescription Drugs market. Moreover, this trend is further anticipated to drive the global Anti-Obesity Prescription Drugs market over the forecast period. Furthermore, growing obesity due unhealthy food and lifestyle such as intake of drugs due to stress, alcohol leads to growing demand for obesity management resulting in growth of this trend.
The report forecast global Anti-Obesity Prescription Drugs market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2028.
First, this report covers the present status and the future prospects of the global Anti-Obesity Prescription Drugs market for 2015-2028.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
F Hoffmann La Roche Ltd
Orexigen Therapeutics, Inc
Novo Nordisk A/s
Arena Pharmaceuticals, Inc
Glaxosmithkline
Vivus, Inc
Boehringer Ingelheim
Alizyme
At the same time, we classify Anti-Obesity Prescription Drugs according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market by Order Type
Orlistat
Phentermine and Topiramate
Bupropion and Naltrexone
Lorcaserin
Liraglutide
Market by Application
Pediatric
Adult
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Anti-Obesity Prescription Drugs market for the forecast period 2020 - 2028?
• What are the driving forces in the Anti-Obesity Prescription Drugs market for the forecast period 2020 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Anti-Obesity Prescription Drugs industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?